Synopsis
Highlights
History
Business
Property
Subsidiaries
Long term debt
Capital stock
Earnings estimates
Business segments
|
Business Summary
Coloplast is a consumer healthcare company. Co.'s operating segments are: Chronic Care, which covers the sale of ostomy care products and continence care products; Interventional Urology, which covers the sale of urological products, including disposable products, as well as research and development (R&D) activities; Wound and Skin Care, which covers the sale of wound and skin care products; and Voice and Respiratory Care, which covers the sale of laryngectomy and tracheostomy products, as well as R&D activities.Pricing Summary
Time Period
Yesterday | 5 Days | 30 Days | |
---|---|---|---|
Close | 11.16 | 11.22 | 11.14 |
Volume | 127,945.00 | 76,038.00 | N/A |
52 Week High/Low : | N/A - N/A | ||
% Price Change (100 Days) : | -15.90 | ||
200-Day Moving Avg. : | 12.48 |
Company News
Corporate Events
Key Executives
Chief Executive Officer,President | ||
Senior Vice President | ||
Executive Vice President,Chief Financial Officer | ||
Executive Vice President | ||
Executive Vice President | ||
Key Financials
(In DKK as of 09/30/2024)Income Statement | |
---|---|
Revenue | 27,030m |
Net Income | 5,052m |
EPS - Net Income - Diluted | 22.46 |
Revenue per Share | 119.86 |
Balance Sheet | |
Total Assets | 48,073m |
Total Liabilities | 30,131m |
Shareholders' Equity | 17,942m |
Total Assets per Share | 213.34 |
Net Assets per Share | 79.62 |
Cash Flows | |
Cash from Operations | 2,766m |
Cash from Investing | -1,336m |
Cash from Financing | -1,518m |
Cash Flow per Share | 12.30 |